All stock lists
Pelthos Therapeutics Inc. (New York Stock Exchange Arca:PTHS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
17.00-2.59 (-13.22%)
Insider Score
––Not scored
PTHS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PTHS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 15.60 M | 10.91 M | 9.39 M | 7.41 M | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 4.93 M | 5.31 M | 4.39 M | 4.97 M | 0.00 | 0.00 |
| Gross Profit | 10.67 M | 5.59 M | 5.00 M | 2.43 M | 0.00 | 0.00 |
| SG&A Expense | 27.39 M | 17.46 M | 15.75 M | 16.97 M | 2.72 M | 1.64 M |
| R&D Expense | 600.00 K | 186.00 K | 374.00 K | 145.00 K | 514.81 K | 194.30 K |
| Operating Expenses | 28.00 M | 18.68 M | 17.00 M | 17.79 M | 3.23 M | 1.83 M |
| Operating Income | -17.32 M | -13.09 M | -12.00 M | -15.36 M | -3.23 M | -1.83 M |
| Pretax Income | -23.42 M | -10.24 M | -28.59 M | -16.70 M | -3.45 M | -1.97 M |
| Tax Provision | 0.00 | 0.00 | -6.92 M | -465.00 K | 0.00 | 0.00 |
| Net Income | -23.42 M | -10.24 M | -21.66 M | -16.24 M | -3.45 M | -1.97 M |
| EPS (Basic) | -6.62 | -3.09 | -6.87 | -25.35 | -5.38 | -3.20 |
| EPS (Diluted) | -6.62 | -3.09 | -6.87 | -25.35 | -5.38 | -3.20 |
| Shares Outstanding | 3.54 M | 3.31 M | 3.15 M | 640.52 K | 640.52 K | 612.79 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.